These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22149323)

  • 1. Caffeine Expectancy Questionnaire (CaffEQ): construction, psychometric properties, and associations with caffeine use, caffeine dependence, and other related variables.
    Huntley ED; Juliano LM
    Psychol Assess; 2012 Sep; 24(3):592-607. PubMed ID: 22149323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and initial psychometric validation of the Brief-Caffeine Expectancy Questionnaire (B-CaffEQ).
    Kearns NT; Blumenthal H; Natesan P; Zamboanga BL; Ham LS; Cloutier RM
    Psychol Assess; 2018 Dec; 30(12):1597-1611. PubMed ID: 29927303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translation and Validation of the Caffeine Expectancy Questionnaire in Brazil (CaffEQ-BR).
    Mendes GF; Reis CEG; Nakano EY; da Costa THM; Saunders B; Zandonadi RP
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32731330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of a Prescription Stimulant Expectancy Questionnaire.
    Looby A; Earleywine M
    Exp Clin Psychopharmacol; 2010 Aug; 18(4):375-83. PubMed ID: 20695694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine expectancy: instrument development in the Rasch measurement framework.
    Heinz AJ; Kassel JD; Smith EV
    Psychol Addict Behav; 2009 Sep; 23(3):500-11. PubMed ID: 19769434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of the caffeine withdrawal symptom questionnaire: caffeine withdrawal symptoms cluster into 7 factors.
    Juliano LM; Huntley ED; Harrell PT; Westerman AT
    Drug Alcohol Depend; 2012 Aug; 124(3):229-34. PubMed ID: 22341956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the multidimensional framework of the Minnesota nicotine withdrawal scale.
    Cappelleri JC; Bushmakin AG; Baker CL; Merikle E; Olufade AO; Gilbert DG
    Curr Med Res Opin; 2005 May; 21(5):749-60. PubMed ID: 15969874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabis expectancies in substance misusers: French validation of the Marijuana Effect Expectancy Questionnaire.
    Guillem E; Notides C; Vorspan F; Debray M; Nieto I; Leroux M; Lépine JP
    Am J Addict; 2011; 20(6):543-54. PubMed ID: 21999501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Cannabis Expectancy Questionnaire (CEQ) in adult cannabis users in treatment.
    Connor JP; Gullo MJ; Feeney GF; Young RM
    Drug Alcohol Depend; 2011 Jun; 115(3):167-74. PubMed ID: 21163593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can the Brazilian Caffeine Expectancy Questionnaires Differentiate the
    Mendes GF; Reis CEG; Nakano EY; Spineli H; Barreto G; Noronha NY; Watanabe LM; Nonino CB; de Araujo GG; Saunders B; Zandonadi RP
    Nutrients; 2022 Aug; 14(16):. PubMed ID: 36014860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical importance of caffeine dependence and abuse.
    Ogawa N; Ueki H
    Psychiatry Clin Neurosci; 2007 Jun; 61(3):263-8. PubMed ID: 17472594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and initial validation of a caffeine craving questionnaire.
    West O; Roderique-Davies G
    J Psychopharmacol; 2008 Jan; 22(1):80-91. PubMed ID: 18187535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Smoking Abstinence Expectancies Questionnaire-Italian Version: Analysis of psychometric properties.
    Svicher A; Zvolensky MJ; Cosci F
    J Addict Dis; 2017; 36(1):80-87. PubMed ID: 27782790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis.
    Kendler KS; Myers J; O Gardner C
    Psychol Med; 2006 Dec; 36(12):1717-25. PubMed ID: 16893482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding adolescent caffeine use: connecting use patterns with expectancies, reasons, and sleep.
    Bryant Ludden A; Wolfson AR
    Health Educ Behav; 2010 Jun; 37(3):330-42. PubMed ID: 19858312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.
    Kendler KS; Myers J; Prescott CA
    Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine and other substance interaction expectancies questionnaire: relationship of expectancies to substance use.
    Rohsenow DJ; Colby SM; Martin RA; Monti PM
    Addict Behav; 2005 May; 30(4):629-41. PubMed ID: 15833569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Further examination of the psychometric properties of the comprehensive effects of alcohol questionnaire.
    Valdivia I; Stewart SH
    Cogn Behav Ther; 2005; 34(1):22-33. PubMed ID: 15844685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of the Brief Symptom Inventory (BSI) in psychiatric outpatients with intellectual disabilities.
    Wieland J; Wardenaar KJ; Fontein E; Zitman FG
    J Intellect Disabil Res; 2012 Sep; 56(9):843-53. PubMed ID: 21726320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.